drugset / Trial / NCT06089252

Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex

NCT06089252 ↗

Phase 2 Completed 30 enrolled Iveriapharma LLC
NaSingle-groupOpen-labelTreatment

Summary

Study aimed to evaluate the efficacy and tolerance of Lazolex®, an emollient gel, to treat mucocutaneous lesions caused by herpes simplex virus.

Timeline

Start
2007-11-27
Primary completion
2007-12-28
Completion
2008-01-28

Drugs

EvaluationDrugModalityDoseRoute
Subject walnut extract Unknown — Topical